nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftaroline fosamil—Ceftriaxone—GLUL—liver cancer	0.0642	0.908	CrCbGaD
Ceftaroline fosamil—Hypokalaemia—Sorafenib—liver cancer	0.0236	0.0253	CcSEcCtD
Ceftaroline fosamil—Transaminases increased—Epirubicin—liver cancer	0.0217	0.0233	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Sorafenib—liver cancer	0.0209	0.0225	CcSEcCtD
Ceftaroline fosamil—Transaminases increased—Doxorubicin—liver cancer	0.02	0.0216	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Sorafenib—liver cancer	0.0199	0.0215	CcSEcCtD
Ceftaroline fosamil—Infestation—Sorafenib—liver cancer	0.0199	0.0215	CcSEcCtD
Ceftaroline fosamil—Renal failure—Sorafenib—liver cancer	0.0196	0.0211	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Sorafenib—liver cancer	0.0189	0.0203	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Sorafenib—liver cancer	0.0177	0.019	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Sorafenib—liver cancer	0.0175	0.0189	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Sorafenib—liver cancer	0.0162	0.0175	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Sorafenib—liver cancer	0.0162	0.0174	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Sorafenib—liver cancer	0.0156	0.0168	CcSEcCtD
Ceftaroline fosamil—Erythema—Sorafenib—liver cancer	0.0156	0.0168	CcSEcCtD
Ceftaroline fosamil—Anaemia—Sorafenib—liver cancer	0.0144	0.0155	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.0132	0.0142	CcSEcCtD
Ceftaroline fosamil—Hyperkalaemia—Epirubicin—liver cancer	0.0129	0.0139	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Sorafenib—liver cancer	0.0127	0.0137	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Sorafenib—liver cancer	0.0125	0.0134	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Sorafenib—liver cancer	0.0125	0.0134	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Sorafenib—liver cancer	0.0124	0.0133	CcSEcCtD
Ceftaroline fosamil—Hyperkalaemia—Doxorubicin—liver cancer	0.012	0.0129	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Epirubicin—liver cancer	0.0111	0.0119	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Sorafenib—liver cancer	0.011	0.0118	CcSEcCtD
Ceftaroline fosamil—Pain—Sorafenib—liver cancer	0.0109	0.0117	CcSEcCtD
Ceftaroline fosamil—Constipation—Sorafenib—liver cancer	0.0109	0.0117	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Sorafenib—liver cancer	0.0104	0.0112	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Doxorubicin—liver cancer	0.0103	0.0111	CcSEcCtD
Ceftaroline fosamil—Urticaria—Sorafenib—liver cancer	0.0101	0.0109	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Sorafenib—liver cancer	0.0101	0.0108	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Sorafenib—liver cancer	0.0101	0.0108	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Sorafenib—liver cancer	0.00937	0.0101	CcSEcCtD
Ceftaroline fosamil—Pruritus—Sorafenib—liver cancer	0.009	0.00968	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Epirubicin—liver cancer	0.0087	0.00937	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Sorafenib—liver cancer	0.0087	0.00936	CcSEcCtD
Ceftaroline fosamil—Dizziness—Sorafenib—liver cancer	0.00841	0.00905	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Epirubicin—liver cancer	0.00818	0.00881	CcSEcCtD
Ceftaroline fosamil—Vomiting—Sorafenib—liver cancer	0.00809	0.0087	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Doxorubicin—liver cancer	0.00805	0.00867	CcSEcCtD
Ceftaroline fosamil—Rash—Sorafenib—liver cancer	0.00802	0.00863	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Sorafenib—liver cancer	0.00801	0.00862	CcSEcCtD
Ceftaroline fosamil—Headache—Sorafenib—liver cancer	0.00797	0.00857	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Epirubicin—liver cancer	0.00773	0.00832	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Doxorubicin—liver cancer	0.00757	0.00815	CcSEcCtD
Ceftaroline fosamil—Nausea—Sorafenib—liver cancer	0.00755	0.00813	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Epirubicin—liver cancer	0.00746	0.00802	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Epirubicin—liver cancer	0.00737	0.00793	CcSEcCtD
Ceftaroline fosamil—Infestation—Epirubicin—liver cancer	0.00737	0.00793	CcSEcCtD
Ceftaroline fosamil—Renal failure—Epirubicin—liver cancer	0.00724	0.0078	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Doxorubicin—liver cancer	0.00715	0.0077	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Epirubicin—liver cancer	0.00697	0.0075	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Doxorubicin—liver cancer	0.0069	0.00742	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Doxorubicin—liver cancer	0.00682	0.00734	CcSEcCtD
Ceftaroline fosamil—Infestation—Doxorubicin—liver cancer	0.00682	0.00734	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Epirubicin—liver cancer	0.00674	0.00725	CcSEcCtD
Ceftaroline fosamil—Renal failure—Doxorubicin—liver cancer	0.0067	0.00721	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Epirubicin—liver cancer	0.00662	0.00712	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Epirubicin—liver cancer	0.00653	0.00703	CcSEcCtD
Ceftaroline fosamil—Ceftriaxone—ALB—liver cancer	0.00653	0.0924	CrCbGaD
Ceftaroline fosamil—Urethral disorder—Epirubicin—liver cancer	0.00649	0.00698	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Doxorubicin—liver cancer	0.00645	0.00694	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Doxorubicin—liver cancer	0.00623	0.00671	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Doxorubicin—liver cancer	0.00612	0.00659	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Doxorubicin—liver cancer	0.00605	0.00651	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Epirubicin—liver cancer	0.006	0.00646	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Doxorubicin—liver cancer	0.006	0.00646	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Epirubicin—liver cancer	0.00598	0.00643	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Epirubicin—liver cancer	0.00576	0.0062	CcSEcCtD
Ceftaroline fosamil—Erythema—Epirubicin—liver cancer	0.00576	0.0062	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Doxorubicin—liver cancer	0.00555	0.00598	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Doxorubicin—liver cancer	0.00553	0.00595	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Doxorubicin—liver cancer	0.00533	0.00573	CcSEcCtD
Ceftaroline fosamil—Erythema—Doxorubicin—liver cancer	0.00533	0.00573	CcSEcCtD
Ceftaroline fosamil—Anaemia—Epirubicin—liver cancer	0.00532	0.00573	CcSEcCtD
Ceftaroline fosamil—Palpitations—Epirubicin—liver cancer	0.00509	0.00548	CcSEcCtD
Ceftaroline fosamil—Convulsion—Epirubicin—liver cancer	0.00499	0.00537	CcSEcCtD
Ceftaroline fosamil—Anaemia—Doxorubicin—liver cancer	0.00493	0.0053	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00487	0.00524	CcSEcCtD
Ceftaroline fosamil—Palpitations—Doxorubicin—liver cancer	0.00471	0.00507	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Epirubicin—liver cancer	0.0047	0.00506	CcSEcCtD
Ceftaroline fosamil—Convulsion—Doxorubicin—liver cancer	0.00462	0.00497	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Epirubicin—liver cancer	0.00461	0.00496	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Epirubicin—liver cancer	0.0046	0.00495	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Epirubicin—liver cancer	0.00457	0.00491	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00451	0.00485	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Doxorubicin—liver cancer	0.00435	0.00468	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Doxorubicin—liver cancer	0.00427	0.00459	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Doxorubicin—liver cancer	0.00426	0.00458	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Doxorubicin—liver cancer	0.00422	0.00455	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Epirubicin—liver cancer	0.00406	0.00437	CcSEcCtD
Ceftaroline fosamil—Pain—Epirubicin—liver cancer	0.00402	0.00433	CcSEcCtD
Ceftaroline fosamil—Constipation—Epirubicin—liver cancer	0.00402	0.00433	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Epirubicin—liver cancer	0.00384	0.00414	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00375	0.00404	CcSEcCtD
Ceftaroline fosamil—Urticaria—Epirubicin—liver cancer	0.00373	0.00402	CcSEcCtD
Ceftaroline fosamil—Pain—Doxorubicin—liver cancer	0.00372	0.004	CcSEcCtD
Ceftaroline fosamil—Constipation—Doxorubicin—liver cancer	0.00372	0.004	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Epirubicin—liver cancer	0.00372	0.004	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Epirubicin—liver cancer	0.00372	0.004	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Doxorubicin—liver cancer	0.00356	0.00383	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Epirubicin—liver cancer	0.00346	0.00373	CcSEcCtD
Ceftaroline fosamil—Urticaria—Doxorubicin—liver cancer	0.00345	0.00372	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Doxorubicin—liver cancer	0.00344	0.0037	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Doxorubicin—liver cancer	0.00344	0.0037	CcSEcCtD
Ceftaroline fosamil—Pruritus—Epirubicin—liver cancer	0.00333	0.00358	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Epirubicin—liver cancer	0.00322	0.00346	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Doxorubicin—liver cancer	0.0032	0.00345	CcSEcCtD
Ceftaroline fosamil—Dizziness—Epirubicin—liver cancer	0.00311	0.00334	CcSEcCtD
Ceftaroline fosamil—Pruritus—Doxorubicin—liver cancer	0.00308	0.00331	CcSEcCtD
Ceftaroline fosamil—Vomiting—Epirubicin—liver cancer	0.00299	0.00322	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Doxorubicin—liver cancer	0.00298	0.0032	CcSEcCtD
Ceftaroline fosamil—Rash—Epirubicin—liver cancer	0.00296	0.00319	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Epirubicin—liver cancer	0.00296	0.00319	CcSEcCtD
Ceftaroline fosamil—Headache—Epirubicin—liver cancer	0.00294	0.00317	CcSEcCtD
Ceftaroline fosamil—Dizziness—Doxorubicin—liver cancer	0.00288	0.00309	CcSEcCtD
Ceftaroline fosamil—Nausea—Epirubicin—liver cancer	0.00279	0.003	CcSEcCtD
Ceftaroline fosamil—Vomiting—Doxorubicin—liver cancer	0.00277	0.00298	CcSEcCtD
Ceftaroline fosamil—Rash—Doxorubicin—liver cancer	0.00274	0.00295	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Doxorubicin—liver cancer	0.00274	0.00295	CcSEcCtD
Ceftaroline fosamil—Headache—Doxorubicin—liver cancer	0.00272	0.00293	CcSEcCtD
Ceftaroline fosamil—Nausea—Doxorubicin—liver cancer	0.00258	0.00278	CcSEcCtD
